MEREDITH BRANDON: Open Payments
NPI 1902172265 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 44 payments from 6 companies in 2025. Trend: 2023 $60 · 2024 $256 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $176 |
| Teva Pharmaceuticals USA, Inc. | 12 | $173 |
| Alkermes, Inc. | 8 | $152 |
| Lundbeck LLC | 6 | $103 |
| Neurocrine BioSciences, Inc. | 3 | $62 |
| Janssen Pharmaceuticals, Inc | 3 | $47 |
Products named: ABILIFY ASIMTUFII, ARISTADA, AUSTEDO XR, REXULTI, UZEDY, INGREZZA, INVEGA SUSTENNA, ABILIFY MAINTENA.
Industry payments across NJ — which companies pay providers there.
